Johnson & Johnson (JNJ)
8 Dec 2016
Johnson & Johnson will challenge the fairness of a trial that produced a verdict of $1 billion in damages against the company last week over allegations of design flaws in its Pinnacle hip implant.
LONDON A top-30 investor in Swiss pharmaceutical company Actelion said he would back a takeover approach for the whole company from U.S. rival Johnson & Johnson above 246 Swiss francs.
U.S. President-elect Donald Trump's plan to incentivize U.S. companies to repatriate their swelling overseas cash piles could spur a new wave of dealmaking in a pharmaceutical industry seeking to buy its way into growth.
French drugmaker Sanofi is considering a bid for Swiss biotech company Actelion , rivaling an offer made by U.S. healthcare company Johnson & Johnson , Bloomberg reported.
ZURICH Actelion's silence speaks volumes to the dozens of event-driven hedge funds piling into the Swiss biotech firm, betting that Johnson & Johnson's (J&J) approach will result in an outright takeover and handsome returns.
A federal jury in Dallas on Thursday ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay more than $1 billion to six plaintiffs who said they were injured by Pinnacle hip implants.
ZURICH Shares in Swiss biotech company Actelion fell more than 6 percent after news outlet streetinsider.com reported on Wednesday the company had rejected a full takeover offer by U.S. healthcare group Johnson & Johnson and may sell a unit.
ZURICH/LONDON Some Actelion shareholders would be attracted by a $27 billion bid for the Swiss biotech company from Johnson & Johnson, leaving Chief Executive Jean-Paul Clozel with some explaining to do if he turned down an offer around that level.
Nov 29 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Tuesday:
LONDON U.S. healthcare company Johnson & Johnson has raised its offer for Actelion, a source told Reuters on Tuesday, stepping up pressure on the Swiss biotech firm to accept a takeover deal.
|General Electric Company (GE.N)||$31.53||--|
|Procter & Gamble Co (PG.N)||$83.50||--|
|Pfizer Inc. (PFE.N)||$30.94||--|
|Novartis AG (NOVN.S)||CHF70.55||+2.05|
|Merck & Co., Inc. (MRK.N)||$60.12||--|
|Baxter International Inc (BAX.N)||$44.08||--|
|Stryker Corporation (SYK.N)||$115.51||--|
|Boston Scientific Corporation (BSX.N)||$20.61||--|
|Zimmer Biomet Holdings Inc (ZBH.N)||$104.45||--|